IP Library › Assignment 063552/0654
Patent Assignment
Reel/Frame 063552/0654

Assignment of Assignor's Interest

Recorded: 2023-05-05 Pages: 10
Assignor
ABBVIE INC.
Executed: 2023-04-28
Assignee
MELINTA THERAPEUTICS LLC
389 INTERPACE PARKWAY, SUITE 450, PARSIPPANY, NEW JERSEY, 07054
Covered Properties (3)
High Purity Oritavancin and Method of Producing Same
Patent: 9,649,352 →
Application: 14/801,303 →
Publication: US 2016/0015772
High Purity Oritavancin and Method of Producing Same
Application: 15/439,206 →
Publication: US 2017/0157206
High Purity Oritavancin and Method of Producing Same
Application: 16/437,361 →
Publication: US 2019/0290723
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 6, 2017
From: CHEMBURKAR, SANJAY R.; KNABLE, CARL M.; PETZEL, JAMES; PRUYNE, JULIE J.
To: ABBVIE INC.
Reel/Frame 041183/0774 →
Assignment of Assignor's Interest Feb 7, 2017
From: RAFAI FAR, ADEL; KRISHNA, GOPAL; DING, MIN
To: THE MEDICINES COMPANY
Reel/Frame 041192/0811 →
Assignment of Assignor's Interest Apr 10, 2017
From: CHEMBURKAR, SANJAY R.; KNABLE, CARL M.; PETZEL, JAMES; PRUYNE, JULIE J.
To: ABBVIE INC.
Reel/Frame 041937/0828 →
Assignment of Assignor's Interest Apr 10, 2017
From: RAFAI FAR, ADEL; KRISHNA, GOPAL; DING, MIN
To: THE MEDICINES COMPANY
Reel/Frame 041937/0775 →
Security Interest Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Assignment of Assignor's Interest Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Security Interest Sep 19, 2019
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 050429/0811 →
Intellectual Property Security Agreement Dec 22, 2020
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 054836/0765 →
Amended and Restated Intellectual Property Security Agreement Aug 25, 2022
From: MELINTA THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 061314/0459 →
Termination and Release of Intellectual Property Security Agreement (Patents) at Reel 054836 and Frame 0765 and Reel 061314 and 0459 Aug 29, 2025
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: MELINTA THERAPEUTICS, LLC
Reel/Frame 072772/0097 →